Art. 1 Regulation (EU) 2026/1073

Amendments

In forcesince 6 Mar 2026

Delegated Regulation (EU) 2023/361 is amended as follows:

(1)

In Article 2(1), point (j) is replaced by the following:

‘(j) ‘waiting period’ means the necessary period of time required to demonstrate the absence of the category A disease after emergency protective vaccination against the disease has been carried out in a vaccination zone;’

(2)

In Article 4, the introductory sentence is replaced by the following:

‘Member States shall prohibit the use of the following veterinary medicinal products in animals for the prevention and control of category A and B diseases unless they are used for the prevention and control of the diseases listed in Part 3 of Annex I, and their type and use comply with the conditions set out therein:’

(3)

In Article 7(1), point (a)(ii) is replaced by the following:

‘(ii) emergency protective vaccination, implemented in response to an outbreak of a category A disease, and carried out in any of the following cases:

terrestrial animals at risk of infection that are kept in establishments located in affected Member States or zones thereof, in which category A diseases have not been confirmed nor are suspected in accordance with Article 6(1) and Article 11 of Delegated Regulation (EU) 2020/687;

in response to a change in the risk of introduction of a category A disease in a non-affected Member State or area thereof;

equine animals subject to the derogation provided for in point 1 of Annex III to Delegated Regulation (EU) 2020/687;’

(4)

In Article 7, paragraph 2 is replaced by the following:

‘2. The competent authority may implement the strategies referred to in paragraph 1 simultaneously or consecutively in different kept and wild terrestrial animal populations, in different zones and geographic areas and at different time points throughout an outbreak, and may vary the strategies applied according to the zone or area, species affected or other defining characteristics. In such cases, the competent authority shall include all the strategies applied simultaneously or consecutively in the official vaccination plan after the assessment referred to in Article 5(1), point (a).

When an area where preventive vaccination in accordance with paragraph 1, point (b), is implemented becomes affected by the relevant category A disease and falls under a restricted zone established in accordance with Article 21 of Delegated Regulation (EU) 2020/687, the preventive vaccination plan may continue to be implemented unless the competent authority decides to apply an emergency vaccination to respond to the increased risk.’

(5)

Article 13 is replaced by the following:

1.

When implementing emergency protective vaccination the competent authority shall prohibit:

(a)

the movements of animals and products thereof laid down in Part 3, point 1, of Annexes VII to XVIII;

(b)

the collection of germinal products from animals laid down in Part 3, point 2, of Annexes VII to XVIII;

(c)

in the absence of disease-specific conditions laid down in Part 3, of Annexes VII to XVIII, movements of:

(i)

vaccinated animals from the establishment where they were vaccinated;

(ii)

products from vaccinated animals from the production and/or processing establishments.

2.

By way of derogation from paragraph 1, point (a), the competent authority may allow movements of animals, either:

(a)

if they are subject to compulsory killing after vaccination, in accordance with the official vaccination plan referred to in Article 5(1), point (b), and they are moved to be killed at the nearest suitable place;

or

(b)

if they are not subject to compulsory killing after vaccination, in accordance with the official vaccination plan referred to in Article 5(1), point (b), and they comply with the conditions laid down in Part 3, point 3, of Annexes VII to XVIII.

3.

By way of derogation from paragraph 1, point (a), the competent authority may allow movements of products of animals from the production and/or processing establishment in accordance with the conditions laid down in Part 3, point 3, of Annexes VII to XVIII.

4.

By way of derogation from paragraph 1, point (b), the competent authority may allow the collection of germinal products in accordance with the conditions laid down in Part 3, point (3), of Annexes VII to XVIII.

5.

When implementing emergency vaccination in wild animals the competent authority shall apply in the vaccination zone the disease-specific restrictions and other risk-mitigating measures set out in Part 3 of Annexes VII to XVIII for the relevant disease, where provided specifically for emergency vaccination in wild animals.

6.

In vaccination zones situated in a restricted zone in accordance with Delegated Regulation (EU) 2020/687, the restrictions and other risk-mitigating measures provided for in paragraphs 1 and 5 shall apply in addition to the measures applicable to:

(a)

protection and surveillance zones and further restricted zones where applicable, established in accordance with Article 21(1) of Delegated Regulation (EU) 2020/687 in the event of an outbreak of a category A disease in kept terrestrial animals, until they are lifted in accordance with Articles 39 and 55 of that Regulation;

(b)

infected zones established in accordance with Article 63(1) of Delegated Regulation (EU) 2020/687 in the event of an outbreak of a category A disease in wild animals, until they are lifted in accordance with Article 67 of that Regulation;

(c)

restricted zones established under emergency measures provided for in Articles 71, 257 and 258 of Regulation (EU) 2016/429, and any rules adopted pursuant to Article 71(3) and Article 259 of that Regulation until those measures are lifted.

7.

The measures referred to in paragraphs 1 and 5 shall continue to apply after the measures referred to in paragraph 6 have been lifted.’

(6)

In Article 14(2), point (a) is replaced by the following:

‘(a) they are not included in the list of animals and products, referred to in Article 13(1), points (a) and (b);’

(7)

In the title of Section 2 and in the title and in point (1) of Article 16, ‘recovery’ is replaced by ‘waiting’.

(8)

In Article 9(4), in Article 10(1), in Article 10(2), in Article 14(2), in Article 16(1) and in point (a)(i) of Article 16(2), ‘XIV’ is replaced by ‘XVIII’.

(9)

Annexes VIII, X, XI and XIV are amended in accordance with Part 1 of the Annex to this Regulation.

(10)

Annexes VII, IX, XII and XIII are replaced by the text set out in Part 2 of the Annex to this Regulation.

(11)

New Annexes XV, XVI, XVII and XVIII are added in accordance with Part 3 of the Annex to this Regulation.

(12)

The List of Annexes is replaced by the text set out in Part 4 of the Annex to this Regulation.